Drugs / NVP-1203-R
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT03341832 Comparator | Jan 2018 → Jan 2019 | — | NVP Healthcare | Completed | No outcome recorded |
| Phase 3 | NCT04082975 Comparator | Jan 2020 → May 2021 | — | NVP Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVP-1203-R | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03341832 ↗ |
| Route | Oral | “oral dose for 7 days” NCT03341832 ↗ |